ICI 182,780 (‘FASLODEX’) 250 mg monthly Intramuscular (I.M.) injection shows consistent Pharmacokinetic (PK) profiles when given as either 1 × 5 ml or 2 × 2.5 ml injections in postmenopausal women with Advanced Breast Cancer (ABC)

Authors :: B. Erikstein
John F.R. Robertson
M. Harrison
CK Osborne
John Pippen
Source :: European Journal of Cancer. 37:8-9
Publication Year :: 2001
Publisher :: Elsevier BV, 2001.

Subjects :: Gynecology
Cancer Research
medicine.medical_specialty
Postmenopausal women
Oncology
Pharmacokinetics
business.industry
Advanced breast
Urology
medicine
Cancer
business
medicine.disease

Full Text Access

Tools